BIOMAT Database Logo BIOMAT Database Logo

Does donor and recipient sex influence the development of cardiac allograft vasculopathy? 1995

M R Mehra, and H O Ventura, and A Escobar, and C A Cassidy, and F W Smart, and D D Stapleton
Department of Internal Medicine, Ochsner Clinic, New Orleans, Louisiana, USA.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D005260 Female Females
D006083 Graft Occlusion, Vascular Obstruction of flow in biological or prosthetic vascular grafts. Graft Restenosis, Vascular,Vascular Graft Occlusion,Vascular Graft Restenosis,Graft Restenoses, Vascular,Occlusion, Vascular Graft,Restenosis, Vascular Graft
D006648 Histocompatibility The degree of antigenic similarity between the tissues of different individuals, which determines the acceptance or rejection of allografts. HLA Incompatibility,Histoincompatibility,Human Leukocyte Antigen Incompatibility,Immunocompatibility,Tissue Compatibility,Compatibility, Tissue,HLA Incompatibilities,Histocompatibilities,Histoincompatibilities,Immunocompatibilities,Incompatibility, HLA,Tissue Compatibilities
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor

Related Publications

M R Mehra, and H O Ventura, and A Escobar, and C A Cassidy, and F W Smart, and D D Stapleton
Cardiac allograft vasculopathy: a donor or recipient induced pathology?
March 2015, Journal of cardiovascular translational research,
M R Mehra, and H O Ventura, and A Escobar, and C A Cassidy, and F W Smart, and D D Stapleton
Depletion of recipient CD8+ T cells does not alter the development of cardiac allograft vasculopathy.
February 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation,
M R Mehra, and H O Ventura, and A Escobar, and C A Cassidy, and F W Smart, and D D Stapleton
Influence of traditional cardiovascular risk factors in the recipient on the development of cardiac allograft vasculopathy after heart transplantation.
November 2008, Transplantation proceedings,
M R Mehra, and H O Ventura, and A Escobar, and C A Cassidy, and F W Smart, and D D Stapleton
Predicting the development of cardiac allograft vasculopathy.
January 2014, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology,
M R Mehra, and H O Ventura, and A Escobar, and C A Cassidy, and F W Smart, and D D Stapleton
Influence of pre-existing donor atherosclerosis on the development of cardiac allograft vasculopathy and outcomes in heart transplant recipients.
June 2006, Journal of the American College of Cardiology,
M R Mehra, and H O Ventura, and A Escobar, and C A Cassidy, and F W Smart, and D D Stapleton
Donor or recipient hepatitis B seropositivity is associated with allograft vasculopathy.
March 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation,
M R Mehra, and H O Ventura, and A Escobar, and C A Cassidy, and F W Smart, and D D Stapleton
Depletion of recipient CD4+ but not CD8+ T lymphocytes prevents the development of cardiac allograft vasculopathy.
April 2002, Transplantation,
M R Mehra, and H O Ventura, and A Escobar, and C A Cassidy, and F W Smart, and D D Stapleton
Donor-recipient sex mismatch does not affect graft survivorship after knee osteochondral allograft transplantation.
October 2025, The Knee,
M R Mehra, and H O Ventura, and A Escobar, and C A Cassidy, and F W Smart, and D D Stapleton
Hearts lacking donor-type APCs develop cardiac allograft vasculopathy.
January 1999, Transplantation proceedings,
M R Mehra, and H O Ventura, and A Escobar, and C A Cassidy, and F W Smart, and D D Stapleton
The effects of donor-specific antibody characteristics on cardiac allograft vasculopathy.
December 2021, Clinical transplantation,
Copied contents to your clipboard!